Following the announcement of the NLSDays 2025 panel and the fantastic response it received, Potter Clarkson is bringing the conversation back to Stockholm on 15 October 2025.
If you’re unable to attend NLSDays but still want to hear from this panel, this is a great opportunity to join the discussion.
The panel discussion will unpack Orexo’s decisive US patent litigation victory over Sun Pharma, a milestone case that underscores the critical value of a robust intellectual property strategy. This case offers important insights for innovators, pharma companies, biotech firms, and IP professionals facing aggressive generic competition.
Learn from the experts – Hear from those who lived it:
- Orexo – on the effective use of IP to meet its business objectives, safeguarding life‑changing treatments for opioid dependence;
- Steptoe – US litigators who brought and successfully argued the case before the court; and
- Potter Clarkson – Orexo’s patent attorneys who had a key, central role in preparing the ground for that success
Understand the strategy – See how targeted IP planning can protect market share and innovation pipelines
Take away real‑world lessons – Practical insights on resilience, litigation strategy, and long‑term protection of breakthrough work.
Register here
